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SUMMARY 
The authors present their experience of prophylactic lithium therapy in seven children diagnosed 
as minic depressive psychosis, bipolar type, according to International Classification of Diseases, 9th revi-
sion. The authors demonstrate the effectiveness oflithium as a therapeutic and prophylactic agent for manic 
depressive illness in children. Side-effects are not a problem if serum lithium levels are maintaired between 
0.6—1.2 mEq/L. Renal functions have reamianed un-impaired even after three years oflithium therapy 
in four children. 
Lithium carbonate has now been 
well-established in the prophylaxis and 
treatment of bipolar as well as unipolar 
manic depressive psychosis in adults. 
Its short term side effects and long-term 
sequalae have also been well reported. 
Presence of depression and bipolar affe-
ctive illness in children has been a mat-
ter of controversy for quite some time, 
yet many reports have appeared now 
describing in detail the case-histories 
of children suffering from bipolar 
affective illness (Weinberg and Brum-
back, 1976; Anthony and Scott, 1960; 
Leading article, BMJ, 1979; Khandel-
wal et al.3 1982; Hassanyeh and Davi-
son, 1980). Recent studies (Hassanyeh 
and Davison, 1980; Brumback and We-
inberg, 1977; Feinstein and Wolpert, 
1973; Gram & Rafaelson, 1972) have 
also brought about evidences in favour 
of therapeutic and prophylactic use of 
lithium in children. So far, there have 
been only a few scattered reports having 
small number of cases. However, con-
sensus seems to be emerging in favour 
of beneficial use of lithium in children 
as far as affective illness is concerned. 
Lithium has also been tried with conflict-
ing results in a number of other child-
hood disorders like hyperkinesis (Green-
hill et al., 1973; Whitehead and Clark, 
1970), unsocialized aggressive reaction 
(Sheard, 1975) and childhood schizo-
phrenia (Campbell, 1972). Despite un-
resolved questions such as indicators 
and prognosticators of lithium use, and 
whether to administer for an acute at-
tack and or for prophylaxis, lithium has 
safely been used in children. However, 
information regarding its short-term and 
longterm side effect in children is still 
scanty (Youngerman and Canino, 1978). 
In this paper, we are reporting our ex-
perience of lithium use in seven child-
ren who developed bipolar manic de-
pressive illness between 11-14 years of 
age and were then successfully treated 
with lithium carbonate. 
SUBJECTS AND METHODS 
Seven children diagnosed to be 
suffering from bipolar manic depressive 
illness are included in the study. Three 
were males and four females. Their 
ages varied between 11 to 15 years 
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(mean 14 years). They all were admit-
ted to the Psychiatry ward of the Post-
graduate Institute of Medical Educa-
tion and Research, Chandigarh, India 
for full evaluation and treatment. 
Gases were diagnosed according to the 
International Classification of Diseases 
9th revision (ICD-9) which is applicable 
to both adults and children. 
All the children had suffered vari-
able number of attacks of mania and de-
pression, and before the start of lithium 
the diagnosis of manic depressive psy-
chosis, bipolar type had been fairly well 
established on the basis of history, 
repeated mental state examination and 
observation in the ward. However, in 
some children, some other diagnoses 
were also considered but requisite psy-
chological and physical tests helped rule 
them out. Before starting lithium, bl-
ood haemogram, serum electrolytes and 
creatinine, blood urea, urinary pH and 
thyroid functions were carried out in 
each child and were found normal. 
Informed consent regarding lithium treat-
ment was obtained from parents. Cli-
nical and mental state and physical exa-
mination especially for any side effect 
of lithium were performed daily and re-
corded on a semi-structured proforma. 
Lithium carbonate was given in 3-4 
divided doses, usually in range of 750-
1200 mg/day and serum levels were de-
termined weekly by flame photometer. 
Patients characteristics and important 
clinical features have been summarised 
in Table-I. 
Detailed renal functions were in-
vestigated in those patients who had 
completed more than three years of lith-
ium prophylaxis. For tubular function, 
24-hour urine volume, and urinary 
osmolality were determined, and glo-
merular function was assessed by creati-
nine clearance and 24-hour urinary 
protein. Besides, serum electrolytes, 
serum creatinine and blood urea were 
also measured. For the above tests, 
the children were hospitalized and were 
provided with a standard hospital diet 
of 2000 calories and 8 grams of salt. 
RESULTS 
All children had their first attack 
of affective illness before the age of 15 
years. In three children (S. No. 1, 2, 
5, 6) the illness started with depressive 
phase while in others (S. No. 3, 4, 7) 
it began with mania. All the children 
except case No. 4 had definite family 
history of affective illness. Though the 
diagnosis of manic depressive illness was 
established in all cases before the start 
of lithium prophylaxis, however, in the 
initial stages, some diagnostic difficulties 
had arisen in cases 1, 2, 4 and 6 as 
shown in the table. Treatment received 
prior to lithium has also been charted 
in the table I. 
Table II summarises the age of 
start, daily dose, duration, serum levels, 
response and side-effects of lithium 
carbonate. 
Most of the cases received 750-1000 
mg of lithium carbonate daily in 3-4 
divided doses with an aim of maintaining 
the serum lithium concentration betw-
een 0.6 to 1.2 mEq/L- Case No. 4 re-
ceived 1500 mg of the drug daily for 
first 3 months to achieve therapeutic 
blood levels and then 900 mg/day sub-
sequently, while in case No. 1, lithium 
dose was stepped up to 1000 mg per day 
after atrial of 6 months with 750 mg/ 
day during which his blood levels 
stayed between 0.4-0.65 mEq/L and he 
continued to experience mild symptoms. 
In all the cases, the response to lithium 
therapy was visible within two weeks 
when the intensity of symptoms was re-
markably reduced. All the cases except 
No. 1, became completely asymptomatic 
within 8-12 weeks of the treatment. 
Case No. 1 also became asymptomatic T
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TABLE II. Summary of lithium therapy and its response 
197 
Pa-
tient 
1 
2 
3 
4 
5 
6 
7 
Age at 
start 
of 
lithium 
therapy 
(Yrs.) 
14* 
15 
14 
15* 
14 
17 
15 
Duration 
of lithium 
treatment 
3 yrs. 
4 yrs. 
3 months 
5 yrs. 
6 months 
4 yrs. 
6 months 
Daily lithium 
dose 
750 mg for 6 
moiths 
Then, 
1000 mg. 
1000 mg. 
1000 mg 
1500 mg. 
3 months 
then 900 i 
900 mg. 
750 mg. 
600 mg. 
for 
mg. 
Serum lithium 
levels (mEq/ 
/L) 
0.4—0.65 
with 750 mg 
0.7—0.9 with 
1000 mg 
0.7—0.9 
0.8—1.1 
1.0—1.3 
0.6—0.8 
0.7—1.0 
0.5—0.7 
0.7—0.9 
Response 
Complete 
remission 
Complete 
remission 
Termination 
of excitement 
Complete 
remission 
Termination 
of excitement 
Complete 
remission 
Complete 
remission 
Side-effects 
i. Tremor.; 
ii. Frequency of 
mictruition 
Nausea 
Vomitting 
Tremors 
Nausea 
i. Nausea 
ii. Tremors 
i. Tremors 
ii. Vomitting 
Whether 
lithium 
still 
continuing 
Yes 
Yes 
No 
Yes 
No 
Yes 
Yes 
6 months later when his daily lithium 
dose was increased. In view of recur-
rent nature of illness and significant fa-
mily history of affective illness, all the 
cases were included in the treatment 
programme for a long-term lithium pro-
phylaxis. However, two children (S. 
No. 3 and 5) dropped out of the treat-
ment once they became asymptomatic. 
Both these cases had an attack of excite-
ment each, one year and 6 months 
later, respectively, and both were again 
successfully treated with lithium at out-
patient setting. However, they again 
discontinued treatment. Cases 1,2 ,4, 
6 and 7 have been still on regular lithium 
prophylaxis and are under complete 
remission. Nausea, vomitting and tre-
mors were the frequent side effects, ho-
wever present only in the first 2-3 weeks 
of treatment. Case No. 1 also reported 
increased frequency of micturition but 
transiently only. In no case was there 
any exacerbation of previous symp-
toms or appearance of any new men-
tal symptoms. Renal functions were as-
sessed in detail in cases 1, 2, 4 and 6 
who had been on lithium for more than 
3 years. None of these patients showed 
any glycosuria or proteinuria. Blood 
urea and serum electrolytes were within 
the normal range in all cases. There 
was no case of polyuria, i.e. urinary out-
put exceeding 3 litres per day. All pa-
tients could concentrate their urine about 
500 mOsm/L after over night fluid 
deprivation. Serum creatinine varied 
between 1.0-1.5 mg/100 ml (mean 1.2 
mg/100 ml). Creatinine clearance vari-
ed from 75-110 ml/min with a mean of 
85 ml/min. Quantitative estimation of 
urinary protein excretion in 24 hours 198  S.K.KHANDELWAL etal. 
was in the range of 20-60 mg with 45 
mg as mean. 
DISCUSSION 
In the present study, we have re-
ported our experience of children suffe-
ring from bipolar affective psychosis tre-
ated with lithium carbonate. For dia-
gnostic purposes, we used the criteria of 
affective psychosis given in ICD-9 and 
found them quite satisfactory. These 
criteria also compared well with that of 
other study (Weinberg and Brumback, 
1976). At the time of inclusion in the 
study, diagnosis of manic depressive psy-
chosis, bipolar type was established in 
all cases. However, in cases 4 and 6, 
other diagnoses were considered initially 
and only a longitudinal follow up could 
establish the diagnosis of affective illness. 
Initial difficulties in the diagnosis of an 
affective illness in children have also 
been reported by other workers (Wein-
berg and Brumback, 1976 ; Khandelwal 
et. al., 1982; Hassanyeh & Davison, 
1980; Brumback and Weinberg, 1977). 
In cases 1 and 2 other diagnoses were 
entertained for academic reasons and 
then subsequently ruled out. Cases 3, 
5 and 7 presented with convincing affec-
tive symptoms of episodic nature and in 
them no other diagnosis was considered. 
Because of the bipolar nature of the ill-
ness, all the children were treated with 
lithium carbonate. Other factors which 
guided our decision in this direction 
were recurrent severe episodes causing 
considerable disorganization of personal 
and family lives, and presence of affec-
tive illness in a near family member. 
All the children responded well to 
lithium treatment as described earlier in 
detail. Many studies (Hassanyeh and 
Davison, 1980; Brumback and Wein-
berg, 1977; Feinstein and Wolpert, 1973; 
Gram and Rafaelsen, 1972; Annell, 
1969) point out that when other thera-
peutic regimes had failed, lithium produ-
ced remarkable improvement in children 
having severe behavioural disturbances. 
However in many such reports, no defi-
nite or strict diagnostic criteria were 
used. Younger man and Ganino (1978) 
concluded in their review of lithium car-
bonate use in children and adolescents 
that classical symptomatology of alter-
nating mania and depression was clearly 
responsive to lithium carbonate in all 
the reviewed cases. Another significant 
finding in this review was the presence of 
family history of bipolar affective illness 
in many cases. We have also observed a 
similar finding as six of our patients had 
positive family history. Role of positive 
family history as a prognostic guide to 
lithium therapy in adults has been well 
documented (Mendlewicz et al.y 1973). 
Our results show a similar trend in chil-
dren also, though in absence of a control 
sample we are unable to say conclusively 
if the presence of a family history makes 
the patient more responsive to lithium 
therapy. Effective serum lithium con-
centration were in range of 0.7—1.2 m 
Eq/L as reported in other studies also 
(Hassanyeh and Davison, 1980; Brum-
back and Weinberg, 1977). Case No. 
1 continued to experience mild symp-
toms with serum lithium le\els of 0.4-
0.6 m Eq/t.. However, Frommer (1968) 
reported response with dosage up to 250 
mg/day. Remarkably, all the children 
tolerated the drug well and experienced 
only transient side effects viz., nausea, 
vomiting and tremors. In no case, were 
we forced to stop lithium due to its side 
effects. In our study, no child ever expe-
rienced exacerbation of depressive fea-
tures despite the fact that four of our 
cases have been on lithium prophylaxis 
for more than 3 years. This finding is in 
contrast to the findings of some workers 
(Brumback & Weinberg, 1977; From-
mer, 1968) and similar to another one 
(Hassanyeh and Davison, 1980). Many LITHIUM CARBONATE INM.D.P.  199 
of Frommer's cases required addition of 
a tricyclic antidepressant and in many 
cases lithium therapy had to be discon-
tinued due to exacerbation of depressive 
features. In Brumback and Weinberg's 
series also, five of their six patients sho-
wed a similar exacerbation of depre-
ssion. Electroencephalographic abnor-
malities like diffuse spike-wave bursts 
without any clinical seizures have been 
reported during lithium treatment (Brum-
back and Weinberg, 1977; Gamp-
bell, 1972). However, since we do not 
have the pre-and post treatment EEG 
records of all cases, it is difficult to 
comment on it. Long term effects of 
lithium in adults on their thyroid func-
tions (Schou et al., 1968) and renal 
functions (Hestbech et al., 1977; Vester-
gaard et al., 1979; Khandelwal et al., 
1983) have been well reported. How-
ever no such study has appeared in cases 
of children. In our series, four child-
ren (S. No. 1, 2, 4 and 6) were investi-
gated in detail regarding their renal 
functions. As reported earlier, there 
was no impairment of either tubular or 
glomerular functions. It has been a 
very ecncouraging finding in view of the 
fact that now more and more children 
are likely to be put on lithium for its 
beneficial effects. Schou remarks in a 
study that children tolerate relatively 
large doses of the drug because of their 
high renal lithium clearance, and they 
seemed to be much less prone to side 
effects (Youngerman & Canino, 1978.) 
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